Genflow secures CDAs to explore animal health use of its longevity gene therapy

Genflow Biosciences has entered into two Confidential Disclosure Agreements (CDAs) with leading animal health companies, the company said. These agreements are intended to facilitate data exchange and initiate discussions on potential collaborations. The CDAs align with Genflow’s strategy to apply its proprietary SIRT6-centenarian gene therapy platform in both human and animal health. The company said […] The post Genflow secures CDAs to explore animal health use of its longevity gene therapy appeared first on Longevity.Technology.